SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-010358
Filing Date
2012-02-16
Accepted
2012-02-16 07:30:25
Documents
11
Period of Report
2012-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-5232_18k.htm 8-K 27281
2 EX-99.1 a12-5232_1ex99d1.htm EX-99.1 19527
3 GRAPHIC g52321mmi001.gif GRAPHIC 37675
4 GRAPHIC g52321mmi002.gif GRAPHIC 133603
5 GRAPHIC g52321mmi003.gif GRAPHIC 112138
6 GRAPHIC g52321mmi004.gif GRAPHIC 107320
7 GRAPHIC g52321mmi005.gif GRAPHIC 69211
8 GRAPHIC g52321mmi006.gif GRAPHIC 74822
9 GRAPHIC g52321mmi007.gif GRAPHIC 55897
10 GRAPHIC g52321mmi008.gif GRAPHIC 87868
11 GRAPHIC g52321mmi009.gif GRAPHIC 32220
  Complete submission text file 0001104659-12-010358.txt   1028571
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 12617669
SIC: 2834 Pharmaceutical Preparations